Allurion Reports Initial U.S. Patient Weight Loss Results and Provider Network Expansion

Allurion Technologies reported its initial performance metrics following the U.S. market entry of its weight-loss balloon system, citing early patient outcomes and operational growth. The company confirmed that the first wave of procedures met internal clinical benchmarks while expanding its network of participating medical providers across the country.

The company’s report highlights that patients utilizing the swallowable gastric balloon experienced weight loss results consistent with the data observed during the product’s international rollout. Allurion also noted that it successfully onboarded a targeted number of bariatric clinics and gastroenterology practices during the first phase of the launch. These facilities now offer the procedure as a non-surgical option for weight management. Management stated that the current supply chain infrastructure supports the existing volume of procedures and allows for the planned expansion of the program into additional regional markets throughout the remainder of the year.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 2, 2026

Author

GOAI